- 3.9Impact Factor
- 6.8CiteScore
- 18 daysTime to First Decision
Special Issues
Biomedicines publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Advancing Precision Radiation Oncology in Head and Neck Cancers
Deadline: 31 July 2026
Molecular Research of Chronic Kidney Disease
Deadline: 31 July 2026
State-of-the-Art Immunology and Immunotherapy in Europe (2nd Edition)
Deadline: 30 June 2026
Prostate Cancer Targeted Therapy: Highlighting Advances in Precision Medicine and Rational Combination Approaches
Deadline: 30 June 2026
Advanced Research on the Role of Biogenic Amines in Physiological and Pathological Conditions
Deadline: 30 June 2026
Renin-Angiotensin System in Cardiovascular Biology, 2nd Edition
Deadline: 30 June 2026
Diagnostic and Therapeutic Challenges of CAR-T Cell Therapy
Deadline: 30 June 2026
Updates on Kawasaki Disease
Deadline: 30 June 2026
Sphingolipid Metabolism and Signaling in Health and Diseases: 2nd Edition
Deadline: 30 June 2026
Oxidative Stress and Inflammation: From Mechanisms to Therapeutic Approaches (4th Edition)
Deadline: 30 June 2026
Inherited Retinal Diseases: From Pathomolecular Mechanisms to Therapeutic Strategies, 2nd Edition
Deadline: 30 June 2026
Dualistic Equilibrium in Neurotransmission and Beyond: Unraveling the Pathophysiology and Unlocking Novel Therapeutic Targets in Neuropsychiatric Disorders—2nd Edition
Deadline: 30 June 2026
of 148

